title: ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation.
authors.forename: Pasi
authors.initials: P
authors.lastname: Penttinen
authors.forename: Mike
authors.initials: M
authors.lastname: Catchpole
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005062:European Union; D006291:Health Policy; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D015201:Meta-Analysis as Topic; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome; D053243:Zanamivir / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D009439:Neuraminidase; D053243:Zanamivir